Загрузка...
Forging a potent vaccine adjuvant: CpG ODN/cationic peptide nanorings
Type I interferon inducers may potentially be engineered to function as antiviral and anticancer agents, or alternatively, vaccine adjuvants, all of which may have clinical applications. We recently described a simple strategy to convert a Toll-like receptor 9 (TLR9) agonist devoid of interferon α (...
Сохранить в:
| Опубликовано в: : | Oncoimmunology |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Taylor & Francis
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4292235/ https://ncbi.nlm.nih.gov/pubmed/25610738 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/21624011.2014.950166 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|